Hualan Biological Bacterin Inc. is engaged in the R&D, production and sales of vial vaccines, bacterial vaccines and etc.

Wechat attention
consulting service

Wechat attention
consulting service
contact us
0373-3559991
fax:0373-3519991
Adverse reaction Telephone:0373-3552342
address:Jia No. 1-1, Hualan Avenue, Xinxiang City, Henan Province
            


9月6日中国科学院方新副书记、中科院生物局张知彬局长一行莅临华兰生物,与华兰生物就生物技术科研合作展开座谈。河南省科技厅副厅长易先荣、新乡市市长李庆贵等有关领导出席会议并做了重要讲话。
会议回顾了近年来华兰生物与中科院过程所、上海巴斯德研究所在生物技术领域合作方面所取得的丰硕成果,并就下一步合作方向和模式进行了深入的讨论。为进行更加深入的合作,中科院生物局与华兰生物签署了《共同设立中科院生物技术创新与产业化基金》的合作意向书。方新副书记表示,近年来中科院与华兰生物在产、学、研合作方面效果显著,中科院拥有人才、科研等优势,华兰生物是国内生物制药行业的龙头企业,双方优势互补,同时双方拥有共同的理念,都致力于我国生物技术的发展、国民的生命健康,相信在各级政府的支持下,双方的合作一定会取得***的成功!
                            Hualan Bio rushed to the disaster area in Gansu Province
                        
                        2023-12-28
                            Hualan Vac at China Biological Products Annual Conference
                        
                        2023-04-23
                            Congratulation! Hualan’s Tetanus Vaccine is Now Available!
                        
                        2023-04-10
                            Congratulation! Hualan’s Rabies Vaccine Is Now Available!
                        
                        2023-04-10
                            “Flying Start” in Tiger Year----Innovation Broad Marketing Ceremony of Hualan Bacterin Was Held Successfully
                        
                        2022-03-29
                            Mid-term Review Meeting of Major Special Subject of Critical New Drug Preparation Technology “Construction for Emergency Treatment R&D System of Influenza Vaccine and R&D Subject of Products” was Held
                        
                        2021-10-20
                            ***纪委副书记、监察部部长、国家预防***局局长马馼莅临公司视察
                        
                        2021-10-20
                            中科院与华兰生物科研合作座谈会成功闭幕
                        
                        2021-10-20
                            中国***甲型H1N1流感疫苗获准出厂
                        
                        2021-10-20
                            郑重声明
                        
                        2021-10-20